The introduction of thoracic endografts has revolutionized the management of thoracic aortic disease. Currently, endografts are not FDA-approved for treating thoracic aortic injury (TAI). We report a case of TAI who presented in hemorrhagic shock and preoperative cardiac arrest who was successfully treated with large volume resuscitation, closed chest cardiac massage, exploratory laparotomy, and thoracic endografting.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/j.1540-8191.2007.00425.x | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!